Navigation Links
Hope for transplant patients as study finds key to organ scarring
Date:11/10/2013

Patients with damaged organs could be helped by new treatments after scientists have discovered how tissues scar.

Researchers say that the finding could pave the way for new drugs and eventually reduce the number of patients on organ transplant waiting lists.

Fibrotic diseases occur in many tissues within the body including the liver, lung or kidneys and have a range of causes including viruses or toxins. Experts say that the main source of scar tissue is found in specialised cells called Myofibroblasts.

The study discovered that a molecule on these cells is a key regulator of fibrotic disease.

Scientists say that the molecule called alpha v integrin is a critical switch involved in turning on the myofibroblast cells to make scar tissue.

The team studied specially bred mice with fibrosis to see if removing the alpha v integrin molecule on myofibroblasts would reduce the amount of scar tissue in their organs.

Researchers found that when they removed alpha v integrin from these cells, the mice were protected from fibrosis of the liver, lung and kidneys.

They also found that when they treated the mice with a new experimental drug designed to block alpha v integrins, the animals were protected from liver and lung fibrosis.

Dr Neil Henderson, a Wellcome Trust clinical scientist and consultant hepatologist at the University of Edinburgh / MRC Centre for Inflammation Research, said: "When tissue scarring becomes severe, affected organs do not work properly and currently the only treatment for end-stage organ failure is transplantation. However the shortage of donor organs means that many patients die while waiting for surgery.

"Therefore, the development of new therapies to treat fibrosis and reduce the need for organ transplantation would potentially be a major step forward in the treatment of patients with these devastating diseases."


'/>"/>

Contact: Eleanor Cowie
eleanor.cowie@ed.ac.uk
44-131-650-6382
University of Edinburgh
Source:Eurekalert

Page: 1

Related medicine news :

1. Discovery could help to develop drugs for organ transplant and cancer patients
2. Xenotransplantation as a therapy for type 1 diabetes
3. First, Second Kidney Transplants Have Similar Success: Study
4. Lenalidomide prolongs disease control for multiple myeloma patients after stem cell transplant
5. Statins prevent cancer in heart transplant recipients
6. U.S. Liver Transplants Declining
7. Study shows antibiotic improves respiratory function in lung transplant patients
8. UCLA launches first face transplantation program in western US
9. Use of Smokers Lungs for Transplant Has Pros, Cons
10. Skin transplant offers new hope for vitiligo patients
11. Haematopoietic stem cell transplantation increases survival in systemic sclerosis patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2020)... ... January 09, 2020 , ... Real World Evidence and Data:, ... 2020 • 1:30-3:00 p.m. EST, https://www.centerwatch.com/rweanddata , How can one ... and identify gaps and challenges when conducting trials? The Tufts Center for the ...
(Date:1/7/2020)... ... January 07, 2020 , ... Destressing the patient payment and billing experience, balancing ... are among the topics to be examined at the HFMA Western Symposium, to be ... executive officer for Healthfuse, a leader in supporting hospitals to more effectively source and ...
(Date:1/7/2020)... and LAS VEGAS (PRWEB) , ... January 06, 2020 , ... ... its formation and unveil its first product: The LumaCare Duo ™. , The ... (#44868) in the Sands Convention Center in Las Vegas, Nevada during CES 2020, the ...
(Date:1/7/2020)... ... , ... MMJ International Holdings, the premier medical cannabis research company, recently announced ... and CBD proprietary drug formulation which will be used for the treatment of Huntington’s ... confident that it will bring much needed relief to patients suffering from the debilitating ...
(Date:1/3/2020)... ... January 03, 2020 , ... Liz Barlowe, MA, CMC was ... (ALCA). Aging Life Care Professionals® have advanced degrees and are experts in health ... and work with the family to provide recommendations for needed goods and services ...
Breaking Medicine News(10 mins):
(Date:1/7/2020)... (PRWEB) , ... January 07, 2020 , ... ... first calibration-free blood pressure (BP) sensor system for integration in hearables and wearables. ... device and consumer electronics manufacturers for inclusion in their products. Embedded in an ...
(Date:1/7/2020)... ... 06, 2020 , ... MemoryCare.com , a comprehensive resource ... Memory Care Facilities in Fargo, North Dakota. The guide identifies 2 memory care ... According to the Alzheimer’s Association , 5.6 million people age 65 and ...
(Date:1/7/2020)... ... 07, 2020 , ... China’s NMPA (CFDA):, Latest Regulatory Updates ... EST, https://www.fdanews.com/chinanpma , China is the second-largest medical device and in ... 20 percent annual growth rate year after year. , Stay up to speed ...
Breaking Medicine Technology: